Skip to main content

Table 1 Demographic and clinical characteristics

From: Evaluation of integrin αvβ3-targeted imaging for predicting disease progression in patients with high-risk differentiated thyroid cancer (using 99mTc-3PRGD2)

Characteristic

Number of patients (%)

Gender

 Female

19 (57.6)

 Male

14 (42.4)

Age at diagnosis (years)

44.5 ± 15.3 (range: 19-73)

Histology

 Papillary

29 (87.9)

 Follicular

4 (12.1)

TNM classification (AJCC 8th)

 T status

  T1

8 (24.2)

  T2

7 (21.2)

  T3

4 (12.1)

  T4

12 (36.4)

  Tx

2 (6.1)

 N status

  N0

3 (9.1)

  N1

29 (87.9)

  Nx

1 (3.0)

 M status

  M0

25 (75.8)

  M1

8 (24.2)

Initial surgery

 TT only

1 (3.0)

 TT + CND

5 (15.2)

 TT + CND + LND

23 (69.7)

 Hemithyroidectomy followed by completion thyroidectomy

4 (12.1)

Baseline Tg with TSH sitimulation (ng/ml) (in patients with negative TgAb)

65.4, < 0.16 - > 500a

Dose of initial RAI treatment (GBq)

4.81, 4.44–6.66a

  1. Abbreviations: TNM tumor-node-metastasis, AJCC American Joint Committee on Cancer, TT total thyroidectomy, CND central neck dissection, LND lateral neck dissection, Tg thyroglobulin, TSH thyroid stimulating hormone, TgAb thyroglobulin antibody, RAI radioactive iodine
  2. aPresented as median, range